Cargando…

Synthetic Receptors for Early Detection and Treatment of Cancer

Over recent decades, synthetic macrocyclic compounds have attracted interest from the scientific community due to their ability to selectively and reversibly form complexes with a huge variety of guest moieties. These molecules have been studied within a wide range of sensing and other fields. Withi...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Frank, Higson, Séamus P. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669836/
https://www.ncbi.nlm.nih.gov/pubmed/37998127
http://dx.doi.org/10.3390/bios13110953
_version_ 1785139785401106432
author Davis, Frank
Higson, Séamus P. J.
author_facet Davis, Frank
Higson, Séamus P. J.
author_sort Davis, Frank
collection PubMed
description Over recent decades, synthetic macrocyclic compounds have attracted interest from the scientific community due to their ability to selectively and reversibly form complexes with a huge variety of guest moieties. These molecules have been studied within a wide range of sensing and other fields. Within this review, we will give an overview of the most common synthetic macrocyclic compounds including cyclodextrins, calixarenes, calixresorcinarenes, pillarenes and cucurbiturils. These species all display the ability to form a wide range of complexes. This makes these compounds suitable in the field of cancer detection since they can bind to either cancer cell surfaces or indeed to marker compounds for a wide variety of cancers. The formation of such complexes allows sensitive and selective detection and quantification of such guests. Many of these compounds also show potential for the detection and encapsulation of environmental carcinogens. Furthermore, many anti-cancer drugs, although effective in in vitro tests, are not suitable for use directly for cancer treatment due to low solubility, inherent instability in in vivo environments or an inability to be adsorbed by or transported to the required sites for treatment. The reversible encapsulation of these species in a macrocyclic compound can greatly improve their solubility, stability and transport to required sites where they can be released for maximum therapeutic effect. Within this review, we intend to present the use of these species both in cancer sensing and treatment. The various macrocyclic compound families will be described, along with brief descriptions of their synthesis and properties, with an outline of their use in cancer detection and usage as therapeutic agents. Their use in the sensing of environmental carcinogens as well as their potential utilisation in the clean-up of some of these species will also be discussed.
format Online
Article
Text
id pubmed-10669836
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106698362023-10-25 Synthetic Receptors for Early Detection and Treatment of Cancer Davis, Frank Higson, Séamus P. J. Biosensors (Basel) Review Over recent decades, synthetic macrocyclic compounds have attracted interest from the scientific community due to their ability to selectively and reversibly form complexes with a huge variety of guest moieties. These molecules have been studied within a wide range of sensing and other fields. Within this review, we will give an overview of the most common synthetic macrocyclic compounds including cyclodextrins, calixarenes, calixresorcinarenes, pillarenes and cucurbiturils. These species all display the ability to form a wide range of complexes. This makes these compounds suitable in the field of cancer detection since they can bind to either cancer cell surfaces or indeed to marker compounds for a wide variety of cancers. The formation of such complexes allows sensitive and selective detection and quantification of such guests. Many of these compounds also show potential for the detection and encapsulation of environmental carcinogens. Furthermore, many anti-cancer drugs, although effective in in vitro tests, are not suitable for use directly for cancer treatment due to low solubility, inherent instability in in vivo environments or an inability to be adsorbed by or transported to the required sites for treatment. The reversible encapsulation of these species in a macrocyclic compound can greatly improve their solubility, stability and transport to required sites where they can be released for maximum therapeutic effect. Within this review, we intend to present the use of these species both in cancer sensing and treatment. The various macrocyclic compound families will be described, along with brief descriptions of their synthesis and properties, with an outline of their use in cancer detection and usage as therapeutic agents. Their use in the sensing of environmental carcinogens as well as their potential utilisation in the clean-up of some of these species will also be discussed. MDPI 2023-10-25 /pmc/articles/PMC10669836/ /pubmed/37998127 http://dx.doi.org/10.3390/bios13110953 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Davis, Frank
Higson, Séamus P. J.
Synthetic Receptors for Early Detection and Treatment of Cancer
title Synthetic Receptors for Early Detection and Treatment of Cancer
title_full Synthetic Receptors for Early Detection and Treatment of Cancer
title_fullStr Synthetic Receptors for Early Detection and Treatment of Cancer
title_full_unstemmed Synthetic Receptors for Early Detection and Treatment of Cancer
title_short Synthetic Receptors for Early Detection and Treatment of Cancer
title_sort synthetic receptors for early detection and treatment of cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669836/
https://www.ncbi.nlm.nih.gov/pubmed/37998127
http://dx.doi.org/10.3390/bios13110953
work_keys_str_mv AT davisfrank syntheticreceptorsforearlydetectionandtreatmentofcancer
AT higsonseamuspj syntheticreceptorsforearlydetectionandtreatmentofcancer